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Getting it Right: validating a 
culturally specific screening tool 
for depression (aPHQ-9) in 
Aboriginal and Torres Strait 
Islander Australians 
Abstract 
Objectives: To determine the validity, sensitivity, specificity and acceptability of the 
culturally adapted nine-item Patient Health Questionnaire (aPHQ-9) as a screening tool 
for depression in Aboriginal and Torres Strait Islander people. 
Design: Prospective observational validation study, 25 March 2015  – 2 November 2016. 
Setting, participants: 500 adults (18 years or older) who identified as Aboriginal or 
Torres Strait Islander people and attended one of ten primary health care services or 
service events in urban, rural and remote Australia that predominantly serve Indigenous 
Australians, and were able to communicate sufficiently to respond to questionnaire and 
interview questions. 
Main outcome measures: Criterion validity of the aPHQ-9, with the criterion standard 
the depression module of the Mini-International Neuropsychiatric Interview (MINI) 
6.0.0. 
Results: 108 of 500 participants (22%; 95% CI, 18–25%) had a current episode of major 
depression according to the MINI criterion. The sensitivity of the aPHQ-9 algorithm for 
diagnosing a current major depressive episode was 54% (95% CI, 40–68%), its specificity 
was 91% (95% CI, 88–94%), with a positive predictive value of 64%. For screening for a 
current major depressive episode, the area under the receiver operator characteristic curve 
was 0.88 (95% CI, 0.85–0.92); with a cut-point of 10 points its sensitivity was 84% (95% 
CI, 74–91%) and its specificity 77% (95% CI, 71–83%). The aPHQ-9 was deemed 
acceptable by more than 80% of participants. 
Conclusions: Indigenous Australians found the aPHQ-9 acceptable as a screening tool for 
depression. Applying a cut-point of 10 points, the performance characteristics of the 
aPHQ were good. 
 
Summary box 
The known: Screening tools for depression have not been formally validated for Aboriginal 
and Torres Strait Island people across multiple states and territories in Australia. 
The new: The adapted nine-item Patient Health Questionnaire (aPHQ-9) is an effective 
screening tool for depression; a cut-point score of 10 points provides 84% sensitivity and 
77% specificity. The aPHQ-9 was regarded as acceptable by more than 80% of 
participants. 
The implications: We have an evidence-based tool for screening for depression in 
Indigenous Australians. We must ensure that those applying the aPHQ-9 have the skills 
and resources to confidently assess and identify depression, provide effective treatment, 
and implement effective prevention strategies. 
The burden of disease for mental and substance use disorders, in terms of disability-
adjusted life years (DALYs), was the third highest of all diseases in Australia in 2011.1 
Major depression, a chronic and relapsing disorder, impairs cognitive and emotional 
functioning, has substantial social and economic impacts, and increases the risk of 
premature death.2 Evidence-based management of people with depression in primary care 
is beneficial for their health,3 but the rates of detection, diagnosis and effective 
intervention are inadequate.4 High quality primary care investigations of this problem 
have been undertaken in the United Kingdom and the United States,3 but detection of 
depression in Aboriginal and Torres Strait Islander people (Indigenous Australians) in 
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primary care has been little investigated. 
A recent systematic review of diagnostic psychiatric instruments found that none had 
been formally validated for Indigenous Australians.5 To rectify the paucity of Indigenous 
Australian-specific depression research, a culturally adapted depression screening tool 
validated in multiple Australian states and territories is needed. The nine-item Patient 
Health Questionnaire (PHQ-9)6 has been used for nearly two decades as a screening tool 
for depression and for assessing symptom severity in a wide range of cultural settings, but 
lacked face validity for use in Indigenous Australian communities.7 The PHQ-9 text has 
been re-worded in “Aboriginal English”, and the adapted instrument (aPHQ-9) was found 
to be internally consistent in a study with a community sample of 78 Aboriginal men 
(Cronbach α = 0.776) and women (α = 0.767) from central Australia.8 
The objective of the Getting it Right study was to determine the validity of the aPHQ-9 
as a tool for screening Indigenous people attending primary health care services for 
depression, comparing it with the standard tool, the MINI International Neuropsychiatric 
Interview (MINI) 6.0.0.9  
While adapting the aPHQ-9 for use with people from five Aboriginal language groups, 
seven key features of depression in Indigenous Australian men not covered by the aPHQ-
9 were identified: anger, weakened spirit, homesickness, irritability, excessive worry, 
rumination, and drug or alcohol use.8 Additional questions were developed for assessing 
these features; we will report our findings regarding these questions in a separate article. 
Methods 
Study design and participants 
Getting it Right was a prospective, observational diagnostic accuracy study undertaken in 
ten Indigenous primary health care services in the Australian Capital Territory, New 
South Wales (four sites), the Northern Territory (two sites), Queensland, South Australia, 
and Western Australia. The protocol10 was conceived and designed in accordance with the 
principles of reciprocity, respect, equality, responsibility, survival and protection, and 
spirit and integrity.11 The study was coordinated by the George Institute for Global Health 
in Sydney. 
Participants were recruited between 25 March 2015 and 2 November 2016. People 
were eligible for the study if, at the time of their presentation to a participating health 
service or health service event, they were at least 18 years of age, identified as 
Indigenous Australians, were able to communicate sufficiently to respond to the 
questionnaire and interview questions, and gave informed consent. People with a 
diagnosis of psychosis or bipolar disorder were excluded. Trained staff members at each 
service were asked to screen all people attending the service on recruitment days and to 
record written or verbal informed consent for those who agreed to participate. At two 
services, staff members did not always recruit consecutive patients, but sometimes 
selected as potential candidates people they had met previously and believed were more 
likely to participate. 
Study outcomes 
We assessed the criterion validity of the aPHQ-9. The reference criterion standard was a 
diagnosis of depression with the MINI 6.0.0,9 a structured interview for the major 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) Axis I psychiatric 
disorders; we removed the bereavement exclusion criterion for major depression, as 
foreshadowed for DSM-5. The MINI, which can be modularised and administered by 
clinicians and lay interviewers after appropriate training, is the most widely used  
structured psychiatric diagnostic interview instrument, having been validated in more 
than 100 countries. The interview and algorithm provide the dichotomous categories, 
“current major depressive episode” and “no current major depressive episode.” 
Procedures 
In the first assessment, a trained (as outlined in the protocol10), culturally competent staff 
member from the primary health care service interviewed each participant, using a printed 
or electronic questionnaire during a face-to-face interview (or, if necessary, by 
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telephone). At the discretion of the interviewer and participant, participants either directly 
answered the eleven aPHQ-9 questions (numbered 1–4, 5a, 5b, 6, 7, 8a, 8b, 9; response 
options: not at all, several days, more than half the days, nearly every day), seven 
additional questions, questions about the acceptability and ease of use of the aPHQ-9, and 
questions on demographic details, or the questionnaire was administered by the 
interviewer in English or the appropriate Aboriginal or Torres Strait Island language. All 
data were entered into a secure online study database. 
Within seven days of the first assessment, a local, trained member of staff who had not 
participated in and was blind to the results of the initial assessment administered the 
major depressive episode/disorder (current or recurrent), generalised anxiety disorder 
(past 6 months), and post-traumatic stress disorder (past month) modules of the MINI in 
face-to-face interviews (or, if necessary, by telephone).  
Each primary health care service had protocols for the follow-up and care of study 
participants presenting with depression, deliberate self-harm, or suicidal ideation or 
intent. If a participant had a psychiatric disorder, their general practitioner was 
encouraged to arrange for re-assessment, treatment, or formal referral according to their 
clinical judgement.10 
Statistical methods 
Sample size: All analyses were conducted in R 3.3.2 (R Project), and required sample 
sizes were calculated with the package samplingbook (https://CRAN.R-
project.org/package=samplingbook). Assuming a prevalence of major depressive episode 
(as assessed with the MINI) of 10% and a true sensitivity of 0.85, a sample size of 500 
participants was required to achieve a precision of 0.1 for the sensitivity 95% confidence 
interval (CI). Assuming a prevalence of 10% and a true specificity of 0.75, 500 
participants were similarly required to achieve a precision of 0.04 for the specificity CI. 
Data analysis: Categorical data were summarised as frequencies and percentages, 
continuous variables as means and standard deviations (SDs) or medians and interquartile 
ranges (IQRs); proportions were compared in 2 tests, means in t tests. We computed the 
area under the receiver operating characteristic (ROC) curve to estimate the 
discrimination of the aPHQ-9. Sensitivities and specificities using different aPHQ-9 
thresholds were computed with a generalised estimation equation (GEE), using a logit 
link and exchangeable working covariance matrix to account for clustering of participants 
by centre. P < 0.05 was deemed statistically significant. 
Primary analysis: The validity of the aPHQ-9 (compared with the MINI) was assessed 
with two common criteria for a major depressive episode: 
 I. the algorithm scoring method, aligned with DSM-IV diagnostic criteria; major 
depressive episode was detected if the responses to questions 1 or 2, and to three five 
or more of questions 13–9 were at least “more than half the days” (for question 9: at 
least “several days”)7,12,13 and 
 II. a total score of 10 points or more, similar to the cut-point for the original PHQ-9 as 
a screening tool.13,14 
The original PHQ-9 scoring method was used, except that each of the two split questions 
(questions 5 and 8 in the original PHQ-9) were scored once only and the higher score 
retained. The properties of other cut-points were explored by constructing ROC curves. 
Sensitivity and specificity were computed for subgroups (eg, people with a chronic 
disease) by logistic regression, allowing adjustment for demographic differences. 
Missing data: Three participants each missed single aPHQ-9 questions (none the 
question about suicidal ideation or intent). We computed a partial score for these 
participants by summing scores for the answered questions, and multiplied it by 9/8 to 
derive their global scores. 
Ethics approval 
The study was approved by the University of Sydney Human Research Ethics Committee 
(HREC) (reference, 2014/361), the Aboriginal Health and Medical Research Council of 
NSW HREC (reference, 1044/14), the ACT Health HREC (reference, ETH.8.14.207), the 
Queensland Health Metro South HREC (reference, HREC/14/QPAH/503), the Central 
Australian HREC (reference, HREC-15-287), the Menzies School of Health Research 
HREC (reference, 2014-2289), the Aboriginal Health Council of South Australia 
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Aboriginal Health Research Ethics Committee (reference, 04-15-622), and the Western 
Australian Aboriginal Health Ethics Committee (reference, 607). Each participating 
health service also approved the conduct of Getting it Right at their service.  
Results 
Ten of the 34 primary health care services invited to participate in Getting it Right agreed 
to participation. Reasons for non-participation included insufficient staff capacity, having 
other research interests, or failure to respond to multiple contact attempts. Initial 
decisions about participation were made by staff in the chief executive office, the social 
and emotional wellbeing team, general practitioners, research staff, or clinical managers. 
Between 25 March 2015 and 2 November 2016, 913 people were screened for 
eligibility, of whom 533 provided informed consent; 530 participants completed the 
aPHQ-9, of whom 500 also completed the clinical MINI interview (Box 1). There were 
no differences in baseline characteristics between these participants and the 30 who did 
not complete the PHQ-9 and MINI (data not shown). 
Most participants (485, 97%) identified as Aboriginal Australians; ten (2%) identified 
as Torres Strait Islanders and five (1%) as both. The mean age of participants was 43 
years (SD, 15 years; range, 18–80 years), 267 were women (53%) and 300 were the main 
income earners in their households (60%) (Box 2). A previous diagnosis of depression 
was reported by 216 (45%) and anxiety by 160 participants (33%) (Box 3). Most 
participants (347, 69%) had been told at some point by a doctor or other health 
professional that they had at least one of the pre-specified chronic health conditions; 74 
(15%) reported four or more pre-specified chronic conditions, while 105 participants 
(21%) reported a health problem that restricted activities of daily living in the two months 
before the study (Box 2). 
The prevalence of a current major depressive episode according to the MINI criterion 
was 22% (95% CI, 18–25%), of generalised anxiety disorder 21% (95% CI, 18–25%), and 
of post-traumatic stress disorder 11% (95% CI, 8–14%). No MINI diagnosis was made for 
347 participants (69%), while 27 participants (5%) met diagnostic criteria for all three 
conditions (Box 4). There were statistically significant associations between having a 
current major depressive episode and arthritis, asthma, obstructive sleep apnoea, having 
an illness that restricted activities of daily living in the preceding two months, and having 
been previously diagnosed with depression or anxiety (Box 2, Box 3). 
The internal consistency of the aPHQ-9 questions was very good (Cronbach α = 0.88). 
Problems with sleeping were the most frequently reported aPHQ-9 item; 189 respondents 
(38%) found it hard to sleep at night or had other problems with sleeping at least “more 
than half the days”. Thoughts of self-harm or killing oneself (a little bit, most of the time, 
or all the time) were reported by 78 participants (16%), including two who felt this way 
all the time. The reporting of other symptoms, most or all the time, ranged from 19% to 
31% (data not shown). 
The sensitivity of the aPHQ-9 DSM-IV algorithm method (criterion I) for diagnosing a 
current major depressive episode was 54% (95% CI, 40–68%), its specificity 91% (95% 
CI, 88–94%), and the positive predictive value (PPV) 64%. 
For screening for a current major depressive episode (criterion II), the area under the 
ROC curve was 0.88 (95% CI, 0.85–0.92). The sensitivity with a cut-point of 10 was 84% 
(95% CI, 74–91%) and the specificity 77% (95% CI, 71–83%); with a cut-point of 9, the 
sensitivity was 87% (95% CI, 78–93%) and the specificity 72% (95% CI, 66–77%), and 
with a cut-point of 11 the sensitivity was 81% (95% CI, 79–89%) and the specificity 82% 
(95% CI, 77–87%) (Box 5, Box 6). The estimates were nearly identical if the three 
incomplete aPHQ-9 questionnaires were excluded from the analysis (data not shown). 
Feedback from participants about the acceptability of the aPHQ-9 was predominantly 
positive, but 65 respondents (13%) felt that some or all questions were too personal (Box 
7). 
Discussion 
In a heterogeneous primary health care population of Indigenous Australian adults across 
six Australian states and territories, we found that the performance of the aPHQ-9 for 
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screening for depression, with a cut-point of 10 points, was good; in primary care 
validation studies of the standard PHQ-9, 10 points was also considered the optimal cut-
point.14 The best positive predictive value for detecting a major depressive episode (64%) 
was obtained when using the DSM-based diagnostic scoring algorithm, although 
sensitivity was low (54%), consistent with other reports on the algorithm approach.13 
The 22% point prevalence of a major depressive episode in our primary health care-
based study is similar to that reported for other Australian general practice populations15 
and higher than that reported in similar studies of Indigenous primary care patients,16,17 
suggesting our recruitment method did not cause selection bias. The generalisability of 
our findings is strengthened by the participation of ten heterogeneous primary health care 
services across Australia; the participants were not involved in the adaptation of the 
aPHQ-9, and regarded the aPHQ-9 as being acceptable. Two earlier validation studies of 
culturally adapted depression screening tools in Indigenous Australians were conducted in 
the same communities in which the original screening tools had been modified, which 
may have limited the generalisability of their results, given the cultural and linguistic 
diversity of Indigenous Australian communities.16,17 No alternative culturally specific 
screening or assessment tools for assessing depression in Indigenous Australians were 
identified in a recent systematic review.18 
We completed structured training for site staff, achieved high rates of interview 
completion, recruited an adequate number of participants with a MINI major depressive 
episode diagnosis to enable subgroup analyses, and complied with the National Health 
and Medical Research Council guidelines for Indigenous health research.11 Ideally, our 
criterion standard would have been a semi-structured, culturally valid psychiatric 
interview, but such a diagnostic assessment is not available.5 However, the interviews 
were conducted by local, culturally aware clinicians. 
Neither the Royal Australian College of General Practitioners (RACGP) national guide 
for preventive health assessment of Aboriginal and Torres Strait Islander people19 nor the 
Royal Australian and New Zealand College of Psychiatrists clinical practice guideline for 
mood disorders20 recommends universal screening for depression of people attending 
primary care services, as stand-alone screening programs have little or no benefit for 
improving the detection and management of depression.21 Similar concerns were 
expressed when Google included a link to the original PHQ-9 for people who searched 
with “am I depressed?” or related questions.22 
The aPHQ-9 screening specificity of 77% (95% CI, 71–83%) and negative predictive 
value of 95% indicate that it reliably differentiates between people who require further 
assessment of their social and emotional wellbeing and people unlikely to have 
depression. The aPHQ-9 is a free, easy to administer, and culturally acceptable tool for 
initiating discussions with Indigenous people about their mood, consistent with 
recommendations by the RACGP national guideline and the Central Australian Rural 
Practitioners Association (CARPA) manual23 to employ the aPHQ-9 for screening 
Indigenous people at high risk of depression when culturally competent, locally 
knowledgeable practitioners have the resources for providing further evaluation and 
guideline-based treatment. 
The aPHQ-9 cannot replace careful assessment and diagnosis, nor should it be used to 
determine the need for treatment. Even at the highest positive predictive value in our 
study, one-third of people identified with the aPHQ-9 as having a major depressive 
episode would not have major depression according to assessment with the MINI, and, 
conversely, we would still miss some people with major depression. Determining the 
consistency (test–retest reliability) and inter-rater reliability of the aPHQ-9 are the next 
steps for ensuring that the aPHQ-9 provides consistent results, regardless of who 
administers the test.  
Apart from screening and diagnosis, assessments for depression may be used in 
epidemiology studies, treatment monitoring, and outcome assessment. We do not yet 
know the responsiveness of the aPHQ-9 scores to treatment of patients. As the evidence 
base for screening for depression increases, we must develop culturally appropriate, cost-
effective interventions for preventing, treating and managing depression in Indigenous 
Australians. 
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Box 1. Flow of participants through the Getting it Right study 
aPHQ-9 = adapted Patient Health Questionnaire. 
* Positive result (possible major depressive episode): responses to questions 1 or 2 and to three or 
more of questions 3–9 were at least “more than half the days” (for question 9: at least “several days”. 
† Determined with the current major depressive episode module of the MINI International 
Neuropsychiatric Interview (MINI). 
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Box 2. Demographic characteristics of the 500 participants in the Getting it Right 
study 
  Major depressive episode*  
 Total No Yes P 
Number of participants 500 392 (78%) 108 (22%)  
Indigenous status    0.60 
Aboriginal 485 (97%) 378 (78%) 107 (22%)  
Torres Strait Islander 10 (2%) 9 (90%) 1 (10%)  
Aboriginal and Torres Strait Islander 5 (1%) 5 (100%) 0  
Language during the interview    0.08 
English only 442 (89%) 339 (77%) 103 (23%)  
English and Aboriginal language 19 (4%) 17 (89%) 2 (11%)  
Aboriginal language only 33 (7%) 30 (91%) 3 (9%)  
Age (years), mean (SD) 43 (15) 44 (15) 42 (12) 0.26 
Sex    0.83 
Women 267 (53%) 208 (78%) 59 (22%)  
Men 233 (47%) 184 (79%) 49 (21%)  
Marital status    0.27 
Never married 200 (40%) 155 (78%) 45 (22%)  
Married/de facto relationship 186 (37%) 150 (81%) 36 (19%)  
Widowed 29 (6%) 26 (90%) 3 (10%)  
Separated but not divorced 53 (11%) 39 (74%) 14 (26%)  
Divorced 29 (6%) 20 (69%) 9 (31%)  
Lived alone    0.90 
No 379 (76%) 297 (78%) 82 (22%)  
Yes 118 (24%) 92 (78%) 26 (22%)  
Main income earner in household    0.65 
No 196 (40%) 157 (80%) 39 (20%)  
Yes 300 (60%) 234 (78%) 66 (22%)  
Someone close died in past 2 months    0.17 
No 328 (66%) 263 (80%) 65 (20%)  
Yes 170 (34%) 127 (75%) 43 (25%)  
Significant illness that restricted daily activities in the 
past 2 months 
  0.001 
No 391 (79%) 319 (82%) 72 (18%)  
Yes 105 (21%) 69 (66%) 36 (34%)  
At least one chronic disease†    0.034 
No 153 (31%) 129 (84%) 24 (16%)  
Yes 347 (69%) 263 (76%) 84 (24%)  
Four or more chronic diseases†    0.13 
No 426 (85%) 339 (80%) 87 (20%)  
Yes 74 (15%) 53 (72%) 21 (28%)  
SD = standard deviation. 
Missing data were not included when calculating proportions. * According to Mini-International 
Neuropsychiatric Interview (MINI) 6.0.0 major depressive episode module. † Heart disease, stroke, 
cancer, diabetes, arthritis, asthma, respiratory disease, chronic kidney disease, obstructive sleep 
apnoea, high blood pressure. 
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Box 3. Self-reported clinical history of 500 participants in the Getting it Right 
study 
  Major depressive episode*  
 Total No Yes P 
Number of participants 500 392 (78%) 108 (2%)  
Depression    < 0.001 
No 266 (55%) 241 (91%) 25 (9%)  
Yes 216 (45%) 136 (63%) 80 (37%)  
Anxiety    < 0.001 
No 326 (67%) 291 (89%) 35 (11%)  
Yes 160 (33%) 93 (58%) 67 (42%)  
Heart disease    0.76 
No 412 (84%) 323 (78%) 89 (22%)  
Yes 76 (16%) 61 (80%) 15 (20%)  
Stroke    0.13 
No 473 (96%) 371 (78%) 102 (22%)  
Yes 22 (4%) 19 (86%) 3 (14%)  
Cancer    0.76 
No 463 (94%) 364 (79%) 99 (21%)  
Yes 31 (6%) 25 (81%) 6 (19%)  
Diabetes    0.86 
No 368 (74%) 290 (79%) 78 (21%)  
Yes 127 (26%) 98 (77%) 29 (23%)  
Arthritis    0.030 
No 374 (77%) 305 (82%) 69 (18%)  
Yes 113 (23%) 80 (71%) 33 (29%)  
Asthma    0.023 
No 348 (71%) 283 (81%) 65 (19%)  
Yes 145 (29%) 104 (72%) 41 (28%)  
Respiratory disease    0.18 
No 442 (90%) 350 (79%) 92 (21%)  
Yes 47 (10%) 33 (70%) 14 (30%)  
Chronic kidney disease   0.53 
No 447 (92%) 349 (78%) 98 (22%)  
Yes 37 (8%) 31 (84%) 6 (16%)  
Obstructive sleep apnoea   0.024 
No 419 (87%) 339 (81%) 80 (19%)  
Yes 62 (13%) 41 (66%) 21 (34%)  
High blood pressure    0.86 
No 333 (68%) 263 (79%) 70 (21%)  
Yes 156 (32%) 120 (77%) 36 (23%)  
Missing data were not included when calculating proportions. * According to Mini-International 
Neuropsychiatric Interview (MINI) 6.0.0 major depressive episode module. 
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Box 4. Proportions of the 500 participants in the Getting it Right study 
diagnosed with at least one of major depressive episode (MDE), generalised 
anxiety disorder (GAD), and post-traumatic stress disorder (PTSD) with the 
Mini-International Neuropsychiatric Interview (MINI) 
 
Box 5. Operational characteristics of the adapted Patient Health Questionnaire 
(aPHQ-9) for screening or diagnosis of a major depressive episode* 
CI = confidence interval. * Prevalence of major depressive episode was 22% according to Mini-
International Neuropsychiatric Interview (MINI) 6.0.0 major depressive episode module. † Estimated 
using generalised estimating equations, taking into account clustering. ‡ Sensitivity/(1 – specificity): the 
likelihood of a positive test result for a person with a current major depressive episode compared with 
that for a person without a current major depressive episode. § (1 – sensitivity)/specificity: the likelihood 
of a negative test result for a person with a current major depressive episode compared with that for a 
person without a current major depressive episode. ¶ Estimated from the raw frequencies for true 
positive and negative results, and false positive and negative results. 
  
Scoring method 
Sensitivity† 
(95% CI) 
Specificity† 
(95% CI) 
Positive 
predictive 
value 
Negative 
predictive 
value 
Positive 
likelihood 
ratio‡ 
Negative 
likelihood 
ratio§ 
Diagnostic 
odds ratio¶ 
Algorithm (criterion I, 
diagnostic) 
54% (40–68%) 91% (88–94%) 64% 88% 6.3 0.5 13 
Score ≥ 8 92% (84–97%) 66% (61–72%) 43% 97% 2.8 0.1 28 
Score ≥ 9 87% (78–93%) 72% (66–77%) 46% 96% 3.1 0.2 20 
Score ≥ 10 (criterion II, 
screening) 
84% (74–91%) 77% (71–83%) 51% 95% 3.7 0.2 18 
Score ≥ 11 81% (79–89%) 82% (77–87%) 56% 94% 4.6 0.2 22 
Score ≥ 12  70% (56–81%) 87% (82–90%) 59% 91% 5.3 0.3 16 
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Box 6. Receiver operating characteristic (ROC) curve for the aPHQ-9 score 
aPHQ-9 = adapted Patient Health Questionnaire. 
The shaded region represents the 95% confidence region for the curve. The scoring cut -points (8, 9, 10, 
11 , 12) are indicated with their respective cross-type 95% confidence intervals (CIs). Area under the 
ROC curve: 88.3% (95% CI, 84.8–91.7%). 
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Box 7. Participant feedback by 500 paticipants in the Getting it Right study 
about the acceptability of the aPHQ-9 and the seven supplementary questions 
Too many questions?  
No, the number of questions was fine 449 (90%) 
It would be better if there were fewer questions/yes, there were too many 32 (6%) 
Don’t care/no opinion  19 (4%) 
Questions were easy to understand?  
Yes, they were easy to understand 434 (87%) 
I understood most of the questions 52 (10%) 
No, they were too confusing 12 (2%) 
Don’t care/no opinion 2 (1%) 
Questions were easy to answer?  
The questions were easy to answer 412 (82%) 
I was able to answer most questions easily 73 (15%) 
The questions were too difficult to answer 10 (2%) 
Don’t care/no opinion  3 (1%) 
The response categories made sense?  
Yes, they were fine  446 (89%) 
There is probably a better way to answer how I felt  33 (7%) 
No, they were not a good way of asking 16 (3%) 
Don’t care/no opinion  5 (1%) 
Felt comfortable answering the questions?  
Yes, I was comfortable answering all the questions 457 (91%) 
I was OK answering most of the questions 33 (7%) 
No, I was not comfortable answering the questions  6 (1%) 
Don’t care/no opinion 4 (1%) 
Had time to answer the questions?  
Yes, there was plenty of time to answer the questions 493 (98%) 
No, I needed more time 2 (1%) 
Don’t care/no opinion 5 (1%) 
Were the questions too personal?  
No, I was comfortable with what was asked 428 (86%) 
Some of the questions were a bit too personal  40 (8%) 
Yes, the questions were all too personal and I didn’t really want to answer 
them 
25 (5%) 
Don’t care/no opinion 7 (1%) 
aPHQ-9 = adapted Patient Health Questionnaire. 
 
